Gilder Gagnon Howe & CO LLC Soma Logic, Inc. Transaction History

Gilder Gagnon Howe & CO LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$4.27 - $8.26 $207,287 - $400,981	-48,545 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$7.07 - $11.62 $154,840 - $254,489	-21,901 Reduced 31.09%	48,545 $389,000
Q4 2021 Feb 14, 2022	SELL	$10.49 - $14.28 $3,776 - $5,140	-360 Reduced 0.51%	70,446 $820,000
Q3 2021 Nov 15, 2021	BUY	$9.94 - $12.77 $703,811 - $904,192	70,806 New	70,806 $877,000

7.48M

Ticker SLGC
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 183,452,992
Description
SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex prot...

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.